Skip to content
Clinical Trials – home

Azienda Ospedaliera Universitaria Di Cagliari

Verified siteinfo

Italy Strada Statale 554 N. 1, 09042 Monserrato, Italy

  • 26 trials recruiting
  • Colorectal cancer metastatic · Asthma · Colitis ulcerative
  • Adults and children

About Specializations

Azienda Ospedaliera Universitaria Di Cagliari in Monserrato, Italy specialises in clinical trials of conditions such as Colorectal cancer metastatic, Asthma, Colitis ulcerative, Crohn's disease, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology Research

At Azienda Ospedaliera Universitaria Di Cagliari, the main focus in oncology is advanced colorectal cancer, with a strong emphasis on patients carrying the KRAS G12C mutation. These studies are designed to assess whether new treatment combinations can improve disease control and offer better options after standard therapy.

  • Advanced colorectal cancer with KRAS G12C mutation
  • Testing new treatment strategies for patients whose disease has progressed after first-line care
  • Comparing targeted therapy combinations with standard chemotherapy

This research helps evaluate whether more precise cancer treatments can improve outcomes for people with difficult-to-treat neoplasms.

Respiratory Disease Studies

The site also conducts clinical research in respiratory tract diseases, especially severe asthma with an eosinophilic phenotype. These trials aim to better understand long-term safety and support more effective control of persistent asthma symptoms in patients already receiving standard care.

  • Severe asthma with an eosinophilic phenotype
  • Evaluating long-term safety of new add-on treatment options
  • Improving management for patients with difficult-to-control asthma

Overall, the respiratory studies are focused on expanding treatment choices and improving the quality of life for people living with chronic asthma.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Strada Statale 554 N. 109042 MonserratoItaly
Recruiting now
26 trials
Conditions studied
35
Partner status
Verified site

More sites in MonserratoItaly

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

60 clinical trials

Asthma

Recruiting

Study to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:Sanofi-Aventis Recherche & Developpement

A study of navenibart for long-term safety in patients with hereditary angioedema

Investigational
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Navenibart
  • Sponsor:Astria Therapeutics Inc.

Crohn's disease

Recruiting

Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC

Crohn's disease

Recruiting

Study of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:RO7790121
  • Sponsor:F. Hoffmann-La Roche AG

Study on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.

Graves' disease

Recruiting

Phase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Asthma

Recruiting

Efficacy and Safety of Depemokimab for Early Intervention in Adults and Adolescents with Type 2 Asthma at Risk of Exacerbations

Registered drug
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Gadoteric Acid

Study to evaluate the efficacy and safety of deucrictibant for the prevention and treatment of angioedema attacks in adults with acquired angioedema

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Deucrictibant
  • Sponsor:Pharvaris Netherlands B.V.

Study of PRAX-628 to evaluate safety and effectiveness in adults with epilepsy who have focal seizures or generalized tonic-clonic seizures

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:PRAX-628
  • Sponsor:Praxis Precision Medicines Inc.

Study comparing cetuximab with chemotherapy versus bevacizumab with chemotherapy in patients with advanced colorectal cancer who have wild-type RAS and right-sided tumors

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Fondazione GONO G.I.

Asthma

Recruiting

Study of PF-07275315 to evaluate its effectiveness and safety in adults with moderate-to-severe asthma who have high levels of eosinophils in their blood

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:Pfizer Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.